Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

Cited In for PubMed (Select 11920157)

1.

Targeted massively parallel sequencing of autism spectrum disorder-associated genes in a case control cohort reveals rare loss-of-function risk variants.

Griswold AJ, Dueker ND, Van Booven D, Rantus JA, Jaworski JM, Slifer SH, Schmidt MA, Hulme W, Konidari I, Whitehead PL, Cuccaro ML, Martin ER, Haines JL, Gilbert JR, Hussman JP, Pericak-Vance MA.

Mol Autism. 2015 Jul 7;6:43. doi: 10.1186/s13229-015-0034-z. eCollection 2015.

2.

Functions of Kinesin Superfamily Proteins in Neuroreceptor Trafficking.

Wang N, Xu J.

Biomed Res Int. 2015;2015:639301. Epub 2015 May 17. Review.

3.

NTRK2 expression levels are reduced in laser captured pyramidal neurons from the anterior cingulate cortex in males with autism spectrum disorder.

Chandley MJ, Crawford JD, Szebeni A, Szebeni K, Ordway GA.

Mol Autism. 2015 May 16;6:28. doi: 10.1186/s13229-015-0023-2. eCollection 2015. Erratum in: Mol Autism. 2015;6:38.

4.

An update of the classical and novel methods used for measuring fast neurotransmitters during normal and brain altered function.

Cifuentes Castro VH, López Valenzuela CL, Salazar Sánchez JC, Peña KP, López Pérez SJ, Ibarra JO, Villagrán AM.

Curr Neuropharmacol. 2014 Dec;12(6):490-508. doi: 10.2174/1570159X13666141223223657.

5.

Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.

Yuan H, Low CM, Moody OA, Jenkins A, Traynelis SF.

Mol Pharmacol. 2015 Jul;88(1):203-17. doi: 10.1124/mol.115.097998. Epub 2015 Apr 22.

PMID:
25904555
6.

The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment.

Acab A, Muotri AR.

Neurotherapeutics. 2015 Jul;12(3):534-45. doi: 10.1007/s13311-015-0354-x.

PMID:
25851569
7.

Prospective MEG biomarkers in ASD: pre-clinical evidence and clinical promise of electrophysiological signatures.

Port RG, Anwar AR, Ku M, Carlson GC, Siegel SJ, Roberts TP.

Yale J Biol Med. 2015 Mar 4;88(1):25-36. eCollection 2015 Mar. Review.

8.

Convergence of circuit dysfunction in ASD: a common bridge between diverse genetic and environmental risk factors and common clinical electrophysiology.

Port RG, Gandal MJ, Roberts TP, Siegel SJ, Carlson GC.

Front Cell Neurosci. 2014 Dec 8;8:414. doi: 10.3389/fncel.2014.00414. eCollection 2014. Review.

9.

Age-related decreased inhibitory vs. excitatory gene expression in the adult autistic brain.

van de Lagemaat LN, Nijhof B, Bosch DG, Kohansal-Nodehi M, Keerthikumar S, Heimel JA.

Front Neurosci. 2014 Dec 8;8:394. doi: 10.3389/fnins.2014.00394. eCollection 2014.

10.

Phenome-wide association study (PheWAS) in EMR-linked pediatric cohorts, genetically links PLCL1 to speech language development and IL5-IL13 to Eosinophilic Esophagitis.

Namjou B, Marsolo K, Caroll RJ, Denny JC, Ritchie MD, Verma SS, Lingren T, Porollo A, Cobb BL, Perry C, Kottyan LC, Rothenberg ME, Thompson SD, Holm IA, Kohane IS, Harley JB.

Front Genet. 2014 Nov 18;5:401. doi: 10.3389/fgene.2014.00401. eCollection 2014.

11.

Synaptic proteins and receptors defects in autism spectrum disorders.

Chen J, Yu S, Fu Y, Li X.

Front Cell Neurosci. 2014 Sep 11;8:276. doi: 10.3389/fncel.2014.00276. eCollection 2014. Review.

12.

Antagonistic control of social versus repetitive self-grooming behaviors by separable amygdala neuronal subsets.

Hong W, Kim DW, Anderson DJ.

Cell. 2014 Sep 11;158(6):1348-61. doi: 10.1016/j.cell.2014.07.049.

PMID:
25215491
13.

The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review.

Rossignol DA, Frye RE.

Front Pediatr. 2014 Aug 22;2:87. doi: 10.3389/fped.2014.00087. eCollection 2014. Review.

14.

Trafficking of kainate receptors.

Pahl S, Tapken D, Haering SC, Hollmann M.

Membranes (Basel). 2014 Aug 20;4(3):565-95. doi: 10.3390/membranes4030565. Review.

15.

Compulsivity in anorexia nervosa: a transdiagnostic concept.

Godier LR, Park RJ.

Front Psychol. 2014 Jul 17;5:778. doi: 10.3389/fpsyg.2014.00778. eCollection 2014. Review.

16.

The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.

Rojas DC.

J Neural Transm. 2014 Aug;121(8):891-905. doi: 10.1007/s00702-014-1216-0. Epub 2014 Apr 22. Review.

PMID:
24752754
17.

Genetic aspects of autism spectrum disorders: insights from animal models.

Banerjee S, Riordan M, Bhat MA.

Front Cell Neurosci. 2014 Feb 24;8:58. doi: 10.3389/fncel.2014.00058. eCollection 2014. Review.

18.

The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome.

Uzunova G, Hollander E, Shepherd J.

Curr Neuropharmacol. 2014 Jan;12(1):71-98. doi: 10.2174/1570159X113116660046.

19.

Environmental toxicants and autism spectrum disorders: a systematic review.

Rossignol DA, Genuis SJ, Frye RE.

Transl Psychiatry. 2014 Feb 11;4:e360. doi: 10.1038/tp.2014.4. Review.

20.

Role of nucleus accumbens glutamatergic plasticity in drug addiction.

Quintero GC.

Neuropsychiatr Dis Treat. 2013;9:1499-512. doi: 10.2147/NDT.S45963. Epub 2013 Sep 30. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk